Valeant Pharmaceuticals Completes Renovation of US Headquarters in New Jersey
Valeant Pharmaceuticals International, Inc. recently celebrated the completion of renovations to its US headquarters in Bridgewater, NJ, with a ribbon-cutting ceremony. The ceremony, which was attended by representatives from the New Jersey Economic Development Authority (EDA), New Jersey Chamber of Commerce, and local elected officials, marked a milestone in the company’s history and signified Valeant’s commitment to bring jobs to the state of New Jersey.
“We are delighted to be finished with the rebuilding project at our US headquarters,” said J. Michael Pearson, Chairman and CEO of Valeant Pharmaceuticals International, Inc. “New Jersey has been our US home for over a decade now, and we have found it to be an ideal business environment. There is a wealth of talented and experienced individuals here that have helped us grow over the years. We are committed to New Jersey and look forward to expanding our presence here.”
Since joining New Jersey’s robust life sciences sector in 2003, Valeant, formerly Biovail Corporation, has continued to grow and expand in the state. After receiving a Grow New Jersey Assistance grant as part of an Economic Development Authority program, the company began making significant investments in its facility to support the current and expected number of employees that it will house. In total, the company invested more $12 million in renovating the office building and utilized over 15 local contractors to complete the work. Valeant currently employs over 400 employees in New Jersey.
“Today’s ceremony is further evidence that the state’s work to attract and retain thriving businesses in the pharmaceutical industry, and the jobs they bring, is working,” said Lt. Governor Guadagno. “After making a commitment in 2013 to grow its footprint and the number of quality, sustainable jobs here in New Jersey, Valeant kept its promises and also made significant investments in its US headquarters that continue to benefit the local economy.”
For more information about Valeant Pharmaceuticals International, Inc., please visit http://www.valeant.com/.
Valeant Pharmaceuticals International, Inc. is a multinational specialty pharmaceutical company that develops, manufactures, and markets a broad range of pharmaceutical products primarily in the areas of dermatology, eye health, neurology, and branded generics. More information about Valeant can be found at www.valeant.com.
Total Page Views: 1947
